NCT02504580
A Pilot Study to Investigate the Safety, Efficacy, Pharmacokinetics and Bioavailability of HTX-011, HTX-002, or HTX-009 Administered Via Injection and/or Topical Application Following Unilateral Open Inguinal Herniorrhaphy
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2015
Completion: Apr 30, 2017